Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
重组串联重复二聚 RBD 蛋白亚单位疫苗 (ZF2001) 对成人 COVID-19 的安全性和免疫原性：两项随机、双盲、安慰剂对照的 1 期和 2 期试验
期刊:Lancet Infectious Diseases
影响因子:36.4
doi:10.1016/S1473-3099(21)00127-4
Shilong Yang, Yan Li, Lianpan Dai, Jianfeng Wang, Peng He, Changgui Li, Xin Fang, Chenfei Wang, Xiang Zhao, Enqi Huang, Changwei Wu, Zaixin Zhong, Fengze Wang, Xiaomin Duan, Siyu Tian, Lili Wu, Yan Liu, Yi Luo, Zhihai Chen, Fangjun Li, Junhua Li, Xian Yu, Hong Ren, Lihong Liu, Shufang Meng, Jinghua
